What is the status of the antiviral drug rintatolimod in the treatment of coronavirus disease 2019 (COVID-19)?

Updated: Jul 01, 2020
  • Author: Medscape Drugs & Diseases; more...
  • Print


Rintatolimod is a TLR-3 agonist (Poly I:Poly C12U; Ampligen; AIM ImmunoTech) (toll-like receptor 3 [TLR-3] agonist) that is being tested as a potential treatment for COVID-19 by the National Institute of Infectious Diseases (NIID) in Japan and the University of Tokyo. [29] It is a broad-spectrum antiviral agent. [30]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!